HMGA1 protein over-expression is a frequent feature of epithelial ovarian carcinomas

Carcinogenesis

Volumn 24, Issue 7, 2003, Pages 1191-1198

  Masciullo, Valeria ^a   Baldassarre, Gustavo ^b,f   Pentimalli, Francesca ^b   Berlingieri, Maria Teresa ^b   Boccia, Angelo ^b   Chiappetta, Gennaro ^c   Palazzo, Juan ^a   Manfioletti, Guidalberto ^d   Giancotti, Vincenzo ^d   Viglietto, Giuseppe ^b   Scambia, Giovanni ^e   Fusco, Alfredo ^b  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c NATIONAL CANCER INSTITUTE   (Italy)

^d UNIVERSITY OF TRIESTE   (Italy)

^e CATHOLIC UNIVERSITY   (Italy)

^f CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; ANTISENSE OLIGONUCLEOTIDE; GREEN FLUORESCENT PROTEIN; HIGH MOBILITY GROUP A PROTEIN; HIGH MOBILITY GROUP A1 PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CARCINOGENESIS; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; EPITHELIUM; GENE OVEREXPRESSION; GENE THERAPY; GROWTH INHIBITION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; METASTASIS POTENTIAL; OVARY ADENOCARCINOMA; OVARY CARCINOMA; OVARY TUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS INHIBITION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE SECTION; WESTERN BLOTTING;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADENOCARCINOMA; ADENOVIRIDAE; DNA PRIMERS; DNA, ANTISENSE; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GRB2 ADAPTOR PROTEIN; HMGA1A PROTEIN; HUMANS; IMMUNOENZYME TECHNIQUES; OVARIAN NEOPLASMS; PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR CELLS, CULTURED;

EID: 0041668179     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/bgg075     Document Type: Article

References (43)

1. Johnson,K.R., Lehn,D.A. and Reeves,R. (1989) Alternative processing of mRNAs encoding mammalian chromosomal high-mobility-group proteins HMG-I and HMG-Y. Mol. Cell. Biol., 9, 2114-2123.
2. Grosschedl,R., Giese,K. and Pagel,J. (1994) HMG domain proteins: architectural in the assembly of nucleoprotein structures. Trends Genet., 10, 94-100.
3. Lovell-Badge,R. (1995) Developmental genetics. Living with bad architecture. Nature, 376, 725-726.
4. Bustin,M. (1999) Regulation of DNA-dependent activities by the functional motifs of the high-mobility-group chromosomal proteins. Mol. Cell. Biol., 19, 5237-5246.
5. Fedele,M., Battista,S., Manfioletti,G., Croce,C.M., Giancotti,V. and Fusco,A. (2001) Role of the high mobility group A proteins in human lipomas. Carcinogenesis, 22, 1583-1591.
6. Zhou,X., Benson,K.F., Ashar,H.R. and Chada,K. (1995) Mutation responsible for the mouse pygmy phenotype in the developmentally regulated factor HMGI-C. Nature, 376, 771-774.
7. Chiappetta,G., Avantaggiato,V., Visconti,R. et al. (1996) High level expression of the HMGI (Y) gene during embryonic development. Oncogene, 13, 2439-2446.
8. Battista,S., Fidanza,V., Fedele,M., Klein-Szanto,A.J., Outwater,E., Brunner,H., Santoro,M., Croce,C.M. and Fusco,A. (1999) The expression of a truncated HMGI-C gene induces gigantism associated with lipomatosis. Cancer Res., 59, 4793-4797.
9. Arlotta,P., Tai,A.K., Manfioletti,G., Clifford,C., Jay,G. and Ono,S.J. (2000) Transgenic mice expressing a truncated form of the high mobility group I-C protein develop adiposity and an abnormally high prevalence of lipomas. J. Biol. Chem., 275, 14394-14400.
10. Melillo,R.M., Pierantoni,G., Scala,S. et al. (2001) Critical role of the HMGI (Y) proteins in adipocytic cell growth and differentiation. Mol. Cell. Biol., 21, 2485-2495.
11. Giancotti,V., Berlingieri,M.T., Di Fiore,P.P., Fusco,A., Vecchio,G. and Crane-Robinson,C. (1985) Changes in nuclear proteins following transformation of rat thyroid epithelial cells by a murine sarcoma retrovirus. Cancer Res., 45, 6051-6057.
12. Giancotti,V., Pani,B., D'Andrea,P. et al. (1987) Elevated levels of a specific class of nuclear phosphoproteins in cells transformed with v-ras and v-mos oncogenes and by co-transfection with c-myc and polyoma middle T genes. EMBO J., 6, 1981-1987.
13. Giancotti,V., Buratti,E., Perissin,L., Zorzet,S., Balmain,A., Portella,G., Fusco,A. and Goodwin,G.H. (1989) Analysis of the HMGI nuclear proteins in mouse neoplastic cells induced by different procedures. Exp. Cell. Res., 184, 538-545.
14. Chiappetta,G., Bandiera,A., Berlingieri,M.T. et al. (1995) The expression of the high mobility group HMGI (Y) proteins correlates with the malignant phenotype of human thyroid neoplasms. Oncogene, 10, 1307-1314.
15. Chiappetta,G., Tallini,G., De Biasio,M.C. et al. (1998) Detection of High Mobility Group I HMGI (Y) proteins in the diagnosis of thyroid tumors: HMGI (Y) expression represents a potential diagnostic indicator of carcinoma. Cancer Res., 58, 4193-4198.
16. Fedele,M., Bandiera,A., Chiappetta,G., Battista,S., Viglietto,G., Manfioletti,G., Casamassimi,A., Santoro,M., Giancotti,V. and Fusco,A. (1996) Human colorectal carcinomas express high levels of high mobility group HMGI (Y) proteins. Cancer Res., 56, 1896-1901.
17. Abe,N.,T. Watanabe,M., Sugiyama,G., Chiappetta,A., Fusco,A. and Atomi,Y. (1999) Analysis of high mobility group I (Y) protein expression in colorectal tumors. Cancer Res., 59, 1169-1174.
18. Chiappetta,G., Manfioletti,G., Pentimalli,F. et al. (2001) High mobility group HMGI (Y) protein expression in human colorectal hyperplastic and neoplastic diseases. Int. J. Cancer, 151, 47-51.
19. Tamimi,Y., van der Poel,H.G., Denyn,M.M., Umbas,R., Karthaus,H.F.M., Debruyne,F.M.J. and Shalken,J.A. (1993) Increased expression of high mobility group protein I (Y) in high grade prostate cancer determined by in situ hybridization. Cancer Res., 53, 5512-5516.
20. Bandiera,A., Bonifacio,D., Manfioletti,G., Mantovani,F., Rustighi,A., Zanconati,F., Fusco,A., Di Bonito,L. and Giancotti,V. (1998) Expression of HMGI (Y) proteins in squamous intraepithelial and invasive lesions of the uterine cervix. Cancer Res., 58, 426-431.
21. Abe,N., Watanabe,T., Masaki,T., Mori,T., Sugiyama,M., Uchimura,H., Fujioka,Y., Chiappetta,G., Fusco,A. and Atomi,Y. (2000) Pancreatic duct cell carcinomas express high levels of high mobility group I (Y) proteins. Cancer Res., 60, 3117-3122.
22. Berlingieri,M.T., Manfioletti,G., Santoro,M., Bandiera,A., Visconti,R., Giancotti,V. and Fusco,A. (1995) Inhibition of HMGI-C protein synthesis suppresses retrovirally induced neoplastic transformation of rat thyroid cells. Mol. Cell. Biol., 15, 1545-1553.
23. Scala,S., Portella,G., Fedele,M., Chiappetta,G. and Fusco,A. (2000) Adenovirus-mediated suppression of HMGI (Y) protein synthesis as potential therapy of human malignant neoplasias. Proc. Natl Acad. Sci. USA, 97, 4256-4261.
24. Wood,L.J., Murkherjee,M., Dolde,C.E., Xu,Y., Maher,J., Bunton,T.E., Willams,J.B. and Resar,L.M.S. (2000) HMG-I/Y, a new c-Myc target gene and potential oncogene. Mol. Cell. Biol., 20, 5490-5502.
25. Wood,L.J., Maher,J.F., Bunton,T.E. and Resar,L.M. (2000) The oncogenic properties of the HMG-I gene family. Cancer Res., 60, 4256-4261.
26. Reeves,R., Edberg,D.D. and Li,Y. (2001) Architectural transcription factor HMGI (Y) promotes tumor progression and mesenchymal transition of human epithelial cells. Mol. Cell. Biol., 21, 575-594.
27. Baldassarre,G., Fedele,M., Battista,S., Vecchione,A., Klein-Szanto,A.J., Santoro,M., Waldmann,T.A., Azimi,N., Croce,C.M. and Fusco,A. (2001) Onset of natural killer cell lymphomas in transgenic mice carrying a truncated HMGI-C gene by the chronic stimulation of the IL-2 and IL-15 pathway. Proc. Natl Acad. Sci. USA, 98, 7970-7975.
28. Banks,E., Beral,V. and Reeves,G. (1997) The epidemiology of epithelial ovarian cancer: a review. Int. J. Gynecol. Cancer, 7, 425-438.
29. Sambrook,J., Fritsch,E.F. and Maniatis,T. (1989) Molecular Cloning: A Laboratory Manual, 2nd Edn. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
30. Parkin,D.M., Muir,C.S., Whelan,S.F. et al. (eds) (1992) Cancer Incidence in Five Continents. IARC Scientific Publications, IARC, Lyon, France.
31. Mant,J.W.F. and Vessey,M.P. (1994) Ovarian and endometrial Cancers. In Doll,R., Fraumeni,J.F. Jr. and Muir,C.S. (eds) Trends in Cancer Incidence and Mortality. Cold Spring Harbor Laboratory, Plainview, NY, pp. 287-307.
32. Masciullo,V., Scambia,G., Marone,M., Giannitelli,C., Ferrandina,G., Bellacosa,A., Benedetti Panici,P. and Mancuso,S. (1997) Altered expression of cyclin D1 and CDK4 genes in ovarian carcinomas. Int. J. Cancer, 74, 390-395.
33. Masciullo,V., Sgambato,A., Pacilio,C., Pucci,B., Ferrandina,G., Palazzo,J., Carbone,A., Cittadini,A., Mancuso,S., Scambia,G. and Giordano,A. (1999) Frequent loss of expression of the cyclin-dependent kinase inhibitor p27 in epithelial ovarian cancer. Cancer Res., 59, 3790-3794.
34. Gayther,S.A., Warren,W., Mazoyer,S. et al. (1995) Germline mutations of the BRCA1 gene in breast and ovarian cancer families provide evidence for a genotype-phenotype correlation. Nature Genet., 11, 428-433.
35. Merajver,S.D., Pham,T.M., Caduff,R.F. et al. (1995) Somatic mutations in the BRCA1 gene in sporadic ovarian tumors. Nature Genet., 9, 439-443.
36. Foster,K.A., Harrington,P., Kerr,J. et al. (1996) Somatic and germline mutations of the BRCA2 gene in sporadic ovarian cancer. Cancer Res., 56, 3622-3625.
37. Trent,M. and Salmon,S.E. (1981) Karyotypic analysis of human ovarian carcinoma cell lines cloned in short term agar. Cancer Genet. Cytogenet., 3, 279-291.
38. Wake,N., Hreshchyshyn,M.M., Piver,S.M., Matsui,S. and Sandberg,A. (1980) Specific cytogenetic changes in ovarian cancer involving chromosomes 6 and 14. Cancer Res., 40, 4512-4518.
39. Trent,J.M., Thompson,F.H. and Buick,R.N. (1985) Generation of clonal variants in human ovarian carcinoma studied by chromosome banding analysis. Cancer Genet. Cytogenet., 14, 153-161.
40. Shayesteh,L., Lu,Y., Kuo,W.L., Baldocchi,R., Godfrey,T. Collins,C., Pinkel,D., Powell,B., Mills,G.B. and Gray,J.W. (1999) PIK3CA is implicated in ovarian cancer. Nature Genet., 21, 99-102.
41. Sato,N., Tsunoda,H., Nishida,M., Morishita,Y., Takimoto,Y., Kubo,T. and Noguchi,M. (2000) Loss of heterozygosity on 10q23.3 and mutation of the tumor suppressor gene PTEN in benign endometrial cyst of the ovary: possible sequence progression from benign endometrial cyst to endometrioid carcinoma and clear cell carcinoma of the ovary. Cancer Res., 60, 7052-7056.
42. Lin,W.M., Forgacs,E., Warshal,D.P., Yeh,I.T., Martin,J.S., Ashfaq,R. and Muller,C.Y. (1998) Loss of heterozygosity and mutational analysis of the PTEN/MMAC1 gene in synchronous endometrial and ovarian carcinomas. Clin. Cancer Res., 4, 2577-2583.
43. Baldassarre,G., Battista,S., Belletti,B., Thakur,S., Pentimalli,F., Trapasso,F., Fedele,M., Pierantoni,M.G., Croce,C.M. and Fusco,A. (2003) Negative regulation of BRCA1 gene expression by HMGA1 proteins accounts for the reduced BRCA1 protein levels in sporadic breast carcinomas. Mol. Cell. Biol., 23, 2225-2238.